1. Home
  2. Stock quotes
  3. Sage Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Sage Therapeutics logo
Sage Therapeutics SAGE
$ 7.29 1.67%
mail-toReport an Error

Quarterly report 2024-Q2
added 07-31-2024

report update icon

Sage Therapeutics EV/EBITDA Ratio 2011-2024 | SAGE

Annual EV/EBITDA Ratio Sage Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.96 4.07 -4.63 -15.1 -24.7 -8.58 -7.89 -22 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.07 -24.7 -10.5